Loading candles…
Aptus Pharma Ltd, incorporated in 2010 and headquartered in Ahmedabad, operates in the pharmaceutical industry. The company focuses on marketing and distributing finished pharmaceutical formulations. Its product portfolio spans over 210 products across more than 11 therapeutic segments, including anti-infectives, gastrointestinal, cardiovascular, anti-diabetic, and nutritional supplements. Aptus Pharma has expanded its offerings from an initial lineup of 11 products to this broader range. The business model involves demand estimation, selection of contract manufacturing partners, and maintaining a strong distribution network. The company does not currently have publicly listed shares, subsidiaries, or disclosed key management personnel and founders.
This page is a live market overview for Aptus Pharma Limited (APPL) on the BSE. As a listed security, Aptus Pharma Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for APPL before placing trades on tick2trade.
As of the latest feed, APPL last traded at ₹279.8 on BSE, down ₹5.7 (2.00%) from the previous close of ₹285.5. Today's session range is ₹279.8 – ₹279.8, against a 52-week band of ₹32.32 – ₹310.25. Traded volume today stands at 2.80K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for APPL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether APPL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Aptus Pharma Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in APPL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated APPL option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.